Loading clinical trials...
Loading clinical trials...
LEveraging A viRtual eNvironment (LEARN) to Enhance Prevention of HIV-related Comorbidities in At-risk Minority MSM
The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
The primary aims of this study are to test the feasibility, acceptability and preliminary effects of a VE to address prevention of HIV-related comorbidities. A waitlist control feasibility clinical trial will be conducted. We will assign (N=80) eligible participants and ensure balanced allocation to intervention and control groups over the intervention period. We hypothesize that the VE will be feasible and acceptable to persons living with HIV, and that they will apply their VE learning to real-life situations and health behaviors for prevention of HIV-related comorbidities.
Age
30 - 65 years
Sex
MALE
Healthy Volunteers
Yes
Yale University
Orange, Connecticut, United States
Start Date
May 10, 2023
Primary Completion Date
March 31, 2025
Completion Date
March 31, 2025
Last Updated
July 28, 2025
78
ACTUAL participants
Gaming in a virtual environment
BEHAVIORAL
Lead Sponsor
Yale University
Collaborators
NCT06909773
NCT06505109
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06189313